Pharmaceuticals

Donepezil Market Expansion Outlook: $1.24 Billion by 2029 Forecast

November 11, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Donepezil Market Between 2025 And 2029?

The donepezil market has experienced consistent expansion in recent years. Its value is projected to climb from $1 billion in 2024 to $1.04 billion in 2025, achieving a compound annual growth rate (CAGR) of 4.1%. This historical growth can be attributed to factors such as the increasing prevalence of Alzheimer’s disease, an expanding geriatric population, a rise in government spending and programs, heightened awareness of neurodegenerative disorders, and an escalating demand for high-quality nucleic acid samples.

The donepezil market is projected to experience consistent expansion over the upcoming years. By 2029, its valuation is anticipated to reach $1.24 billion, expanding at a compound annual growth rate (CAGR) of 4.5%. This anticipated growth during the forecast period is attributable to several factors, including increasing healthcare spending, a heightened emphasis on the early detection of Alzheimer’s, a rising need for combination treatments, increased investment in healthcare infrastructure, and greater awareness of neurodegenerative conditions. Key trends foreseen for this period encompass breakthroughs in drug compositions and administration techniques, advancements in technology, the introduction of new dosage forms and formulations, the authorization of generic versions of donepezil, and enhanced research capabilities.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21174&type=smp

What Are The Top Growth Drivers Impacting The Donepezil Market Outlook?

The increasing occurrence of Alzheimer’s disease is anticipated to boost the expansion of the donepezil market in the future. Alzheimer’s disease is a progressive neurological condition characterized by the degradation and demise of brain cells, leading to memory impairment, cognitive decline, and behavioral alterations. The incidence of Alzheimer’s disease cases is rising due to various factors, including an aging demographic, population growth, lifestyle choices, an increase in chronic illnesses, genetic predispositions, and environmental exposures. Donepezil functions as an effective symptomatic treatment for Alzheimer’s disease by improving cognitive function and daily living capabilities through its influence on acetylcholine levels in the brain. For instance, in May 2024, according to a report by the Alzheimer’s Association, a US-based nonprofit organization dedicated to Alzheimer’s care, support, and research, the count of Americans aged 65 and older diagnosed with Alzheimer’s dementia grew from 6.5 million in 2022 to an estimated 6.9 million in 2024. Consequently, the escalating prevalence of Alzheimer’s is propelling the growth of the donepezil market.

What Are The Different Segment Classifications Within The Donepezil Market?

The donepezil market covered in this report is segmented –

1) By Type: 5mg, 10mg, 23mg

2) By Route Of Administration: Oral, Transdermal

3) By Application: Hospitals, Clinics, Drugstore

Subsegments:

1) By 5mg: Immediate-Release 5mg, Orally Disintegrating 5mg

2) By 10mg: Immediate-Release 10mg, Orally Disintegrating 10mg

3) By 23mg: Extended-Release 23mg, Film-Coated 23mg

What Trends Are Redefining The Donepezil Market Dynamics?

Leading entities in the donepezil market are concentrating on developing advanced technologies, such as the donepezil system, to enhance patient compliance and improve treatment effectiveness through innovative formulations like extended-release. This donepezil system pertains to the pharmacological mechanism or action of donepezil, a medication primarily utilized for addressing Alzheimer’s disease and other forms of dementia. For example, in October 2022, Corium Innovation Inc., a US-based biopharmaceutical company, introduced Adlarity, a donepezil transdermal system, for patients suffering from mild, moderate, or severe Alzheimer disease (AD) dementia. This new transdermal formulation of donepezil delivers the medication directly through the skin, bypassing the digestive system. This particular approach considerably lowers the chance of gastrointestinal side effects and offers a more convenient administration method, providing advantages for both patients with Alzheimer’s disease and their caregivers.

Who Are The Key Multinational Companies Dominating The Donepezil Market?

Major companies operating in the donepezil market are AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Inc., Intas Pharmaceuticals Ltd., Mylan NV, Sandoz Group AG, Hetero Drugs Ltd., Sun Pharmaceutical Inc., Eisai Co. Ltd., Cipla Ltd., Dr Reddy’s Laboratories, Apotex Inc., H Lundbeck A/S, Zydus Cadila, Amneal Pharmaceuticals LLC, Torrent Pharmaceuticals Ltd, Alkem Laboratories Ltd., Jubilant Pharmova Ltd., Wockhardt Ltd., Luoxin Pharmaceuticals Group

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/donepezil-global-market-report

What Regional Growth Trends Are Shaping The Donepezil Market Outlook?

North America was the largest region in the donepezil market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the donepezil market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Donepezil Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21174&type=smp

Browse Through More Reports Similar to the Global Donepezil Market 2025, By The Business Research Company

Alzheimers Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/alzheimers-drugs-global-market-report

Enzyme Inhibitor Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/enzyme-inhibitor-global-market-report

Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tumor-necrosis-factor-inhibitor-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795